173 related articles for article (PubMed ID: 34736988)
1. Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours.
Suffian IFBM; Al-Jamal KT
Adv Drug Deliv Rev; 2022 Jan; 180():114030. PubMed ID: 34736988
[TBL] [Abstract][Full Text] [Related]
2. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
Mohamed Suffian IFB; Wang JT; Hodgins NO; Klippstein R; Garcia-Maya M; Brown P; Nishimura Y; Heidari H; Bals S; Sosabowski JK; Ogino C; Kondo A; Al-Jamal KT
Biomaterials; 2017 Mar; 120():126-138. PubMed ID: 28056402
[TBL] [Abstract][Full Text] [Related]
3. Preparation and preliminary evaluation of hepatitis B core antigen virus like nanoparticles loaded with indocyanine green.
Wang Y; Zhang Y; Yu Y; Ren L; Wang J; Cheng L; Jiang D; Guo X; Teng T; Luo X; Lv S; Wang X; Wang H; Shi X; Zhang H; Bi S
Ann Transl Med; 2020 Dec; 8(24):1661. PubMed ID: 33490173
[TBL] [Abstract][Full Text] [Related]
4. Assembly and Characterization of HBc Derived Virus-like Particles with Magnetic Core.
Rybka JD; Mieloch AA; Plis A; Pyrski M; Pniewski T; Giersig M
Nanomaterials (Basel); 2019 Jan; 9(2):. PubMed ID: 30691173
[TBL] [Abstract][Full Text] [Related]
5. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and characterization of HBc virus like particles with site-directed coupling function].
Liu D; Li B; Bi C; Qiao H; Wu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1440-1449. PubMed ID: 32748602
[TBL] [Abstract][Full Text] [Related]
8. Enhanced assembly and colloidal stabilization of primate erythroparvovirus 1 virus-like particles for improved surface engineering.
Sánchez-Rodríguez SP; Morán-García Adel C; Bolonduro O; Dordick JS; Bustos-Jaimes I
Acta Biomater; 2016 Apr; 35():206-14. PubMed ID: 26911883
[TBL] [Abstract][Full Text] [Related]
9. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
[TBL] [Abstract][Full Text] [Related]
10. Modularized peptides modified HBc virus-like particles for encapsulation and tumor-targeted delivery of doxorubicin.
Shan W; Zhang D; Wu Y; Lv X; Hu B; Zhou X; Ye S; Bi S; Ren L; Zhang X
Nanomedicine; 2018 Apr; 14(3):725-734. PubMed ID: 29275067
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
[TBL] [Abstract][Full Text] [Related]
12. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
[TBL] [Abstract][Full Text] [Related]
13. New generation of viral nanoparticles for targeted drug delivery in cancer therapy.
Alvandi N; Rajabnejad M; Taghvaei Z; Esfandiari N
J Drug Target; 2022 Feb; 30(2):151-165. PubMed ID: 34210232
[TBL] [Abstract][Full Text] [Related]
14. Granting specificity for breast cancer cells using a hepatitis B core particle with a HER2-targeted affibody molecule.
Nishimura Y; Mimura W; Mohamed Suffian IF; Amino T; Ishii J; Ogino C; Kondo A
J Biochem; 2013 Mar; 153(3):251-6. PubMed ID: 23235317
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
16. A novel polyethyleneimine-coated adeno-associated virus-like particle formulation for efficient siRNA delivery in breast cancer therapy: preparation and in vitro analysis.
Shao W; Paul A; Abbasi S; Chahal PS; Mena JA; Montes J; Kamen A; Prakash S
Int J Nanomedicine; 2012; 7():1575-86. PubMed ID: 22619514
[TBL] [Abstract][Full Text] [Related]
17. In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.
Zhang Y; Liu Y; Zhang B; Yin S; Li X; Zhao D; Wang W; Bi J; Su Z
Protein Expr Purif; 2021 Feb; 178():105747. PubMed ID: 32898688
[TBL] [Abstract][Full Text] [Related]
18. The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.
Dishlers A; Skrastina D; Renhofa R; Petrovskis I; Ose V; Lieknina I; Jansons J; Pumpens P; Sominskaya I
Mol Biotechnol; 2015 Dec; 57(11-12):1038-49. PubMed ID: 26446016
[TBL] [Abstract][Full Text] [Related]
19. Hierarchical Coarse-Grained Strategy for Macromolecular Self-Assembly: Application to Hepatitis B Virus-Like Particles.
Depta PN; Dosta M; Wenzel W; Kozlowska M; Heinrich S
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499027
[TBL] [Abstract][Full Text] [Related]
20. Virus-like particle-based nanocarriers as an emerging platform for drug delivery.
Yuan B; Liu Y; Lv M; Sui Y; Hou S; Yang T; Belhadj Z; Zhou Y; Chang N; Ren Y; Sun C
J Drug Target; 2023 Jun; 31(5):433-455. PubMed ID: 36940208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
